1983
DOI: 10.1021/bk-1983-0231.ch005
|View full text |Cite
|
Sign up to set email alerts
|

Immunology and Immunochemistry of Synthetic and Semisynthetic Salmonella O-Antigen-Specific Glycoconjugates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
10
0

Year Published

1986
1986
2011
2011

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(11 citation statements)
references
References 0 publications
1
10
0
Order By: Relevance
“…This is consistent with the common notion that the oligosaccharide component of a conjugate vaccine is often required to have a length in excess of ten residues [5][6][7]. Kabat found that the antidextran antibodies combining site is able to accommodate oligosaccharide composed of up to seven sugar residues [8], Lindberg in his pioneering work showed that octa-and dodecasaccharides isolated by phage mediated degradation of Salmonella O-polysaccharide were optimal for evoking a protective response [9]. Recent studies with synthetic oligosaccharide vaccines have confirmed that 3 repeating units composed of 12-15 monosaccharide residues are preferred over smaller structures for production of protective antibody [7,10].…”
Section: Introductionsupporting
confidence: 80%
“…This is consistent with the common notion that the oligosaccharide component of a conjugate vaccine is often required to have a length in excess of ten residues [5][6][7]. Kabat found that the antidextran antibodies combining site is able to accommodate oligosaccharide composed of up to seven sugar residues [8], Lindberg in his pioneering work showed that octa-and dodecasaccharides isolated by phage mediated degradation of Salmonella O-polysaccharide were optimal for evoking a protective response [9]. Recent studies with synthetic oligosaccharide vaccines have confirmed that 3 repeating units composed of 12-15 monosaccharide residues are preferred over smaller structures for production of protective antibody [7,10].…”
Section: Introductionsupporting
confidence: 80%
“…Increased body temperature after LPS injection has been reported in rabbits (Lindberg et al, 1983), chickens (Klasing et al, 1987a), humans (Michie et al, 1988), and sheep (Sloane et al, 1992). The febrile response has been related to an increased production of the cytokines interleukin-1 (Klasing et al, 1987a) and tumor necrosis factor (Kettelhut et al, 1987).…”
Section: Introductionmentioning
confidence: 99%
“…Such saccharides may be required for the production of synthetic vaccines. S. entericu 0-antigen-specific oligosaccharides have also been produced by enzymatic degradation of the polysaccharide, utilizing bacteriophage glycosidases [4]. So far this procedure has yielded oligosaccharides (monotetramers, ditetramers, tritetramers, and tetramers of a tetrasaccharide) which have terminal sugars different from those of the natural biological repeating unit.…”
mentioning
confidence: 99%